VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > GOAL OF 20 BY YEAR END

<< Previous

Bullboard Posts

Next >>

Post by A637v5c0on Dec 08, 2020 2:41pm

205 Views

Post# 32059634

GOAL OF 20 BY YEAR END

GA stated after halt redemption that there goal was to install 20 units by year end with 1 install per week. They are nowhere near that goal atm, definately under achieved. He also stated 80-100 units sold by the end of 2021 and he also readjusted that goal into the year of 2022. Lack of faith with the underachievements. Will be a while till this stock does make a run, and thats if it will. GLTA

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December